- Home
- ECOR
ECOR
electroCore Inc.
as 06-20-2025 3:34pm EST
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
| Founded: | 2005 | Country: | United States |
| Employees: | N/A | City: | ROCKAWAY |
| Market Cap: | 50.1M | IPO Year: | 2018 |
| Target Price: | $25.50 | AVG Volume (30 days): | 84.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.55 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.46 - $19.49 | Next Earning Date: | 08-06-2025 |
| Revenue: | $26,458,000 | Revenue Growth: | 41.54% |
| Revenue Growth (this year): | 23.21% | Revenue Growth (next year): | 44.10% |
Stock Insider Trading Activity of electroCore Inc. (ECOR)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| GANDOLFO JOHN P | ECOR | Director | May 23 '25 | Buy | $5.01 | 1,800 | $9,018.00 | 69,087 | |
| Errico Thomas J. | ECOR | Director | May 12 '25 | Buy | $4.77 | 10,000 | $47,735.00 | 266,401 |
Latest electroCore Inc. News
ECOR Breaking Stock News: Dive into ECOR Ticker-Specific Updates for Smart Investing
GuruFocus.com
a month ago
electroCore Inc (ECOR) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic ...
Zacks
a month ago
ElectroCore, Inc. (ECOR) Reports Q1 Loss, Misses Revenue Estimates
GlobeNewswire
a month ago
electroCore Announces First Quarter 2025 Financial Results
Insider Monkey
a month ago
electroCore, Inc. (ECOR): A Bull Case Theory
Medical Device Network
2 months ago
electroCore completes acquisition of neurotechnology solution provider NeuroMetrix
MT Newswires
2 months ago
ElectroCore Completes Merger With NeuroMetrix
GlobeNewswire
2 months ago
electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies
GlobeNewswire
2 months ago
electroCore’s Truvaga™ Now Works with the Apple Health app
Compare ECOR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ECOR electroCore Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.